This undiscovered CBD play is on the verge of disrupting the industry
With recent health Canada approval they are poised to explode
Read more here

NVTA Insider Trading (Invitae)

Insider Ownership Percentage: 2.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $47,008,222.95

Invitae Insider Trading History Chart

Invitae Share Price & Price History

$39.80
▼ -2.29 (-5.44%)
As of 02/25/2021 01:00 AM ET
Days: 30 | 90 | 365
Are you looking for the next great pet stock play?
Don't miss this opportunity as FRPT is already trading over 100 dollars per share!
Read more here about the next great pet stock!

Invitae Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/22/2021Geoffrey CrouseDirectorSell10,000$48.62$486,200.0021,459  
1/21/2021Sean E. GeorgeCEOSell8,675$53.80$466,715.00  
1/13/2021Katherine StuelandInsiderSell4,199$51.82$217,592.18  
12/24/2020Jason W MyersInsiderSell48,971$47.97$2,349,138.87518,328  
12/24/2020Kenneth D. KnightCOOSell3,622$50.50$182,911.00  
12/22/2020Jason W MyersInsiderSell224,965$51.55$11,596,945.75806,482  
12/22/2020Sean E. GeorgeCEOSell3,675$53.06$194,995.50  
12/18/2020Jason W MyersInsiderSell253,912$47.49$12,058,280.881,211,099  
12/16/2020Eric AguiarDirectorSell10,000$51.00$510,000.0010,000  
12/16/2020Jason W MyersInsiderSell71,869$47.32$3,400,841.081,211,099  
12/16/2020Kenneth D. KnightCOOSell13,351$51.00$680,901.00  
12/14/2020Katherine StuelandInsiderSell34,300$58.43$2,004,149.00  
11/24/2020Robert F. WernerCAOSell2,427$48.92$118,728.84  
11/20/2020Sean E. GeorgeCEOSell8,683$47.98$416,610.34  
11/18/2020Shelly D. GuyerCFOSell3,000$46.75$140,250.00  
11/17/2020Thomas BridaGeneral CounselSell5,000$46.01$230,050.00  
11/16/2020Eric AguiarDirectorSell30,000$46.52$1,395,600.0010,000  
11/13/2020Katherine StuelandInsiderSell1,000$48.00$48,000.00  
10/13/2020Katherine StuelandInsiderSell1,000$51.36$51,360.00  
9/15/2020Katherine StuelandInsiderSell1,000$35.51$35,510.00  
9/10/2020Robert F. WernerCAOSell246$33.87$8,332.02  
9/10/2020Robert L. NussbaumInsiderSell23,175$33.56$777,753.00  
9/10/2020Sean E. GeorgeCEOSell742$33.87$25,131.54  
9/10/2020Shelly D. GuyerCFOSell631$33.87$21,371.97  
9/10/2020Thomas BridaGeneral CounselSell633$33.87$21,439.71  
8/19/2020Katherine StuelandInsiderSell21,345$32.10$685,174.50  
8/19/2020Robert F. WernerCAOSell1,740$32.10$55,854.00  
8/19/2020Sean E. GeorgeCEOSell15,473$32.10$496,683.30  
8/19/2020Shelly D. GuyerCFOSell18,956$32.10$608,487.60  
8/19/2020Thomas BridaGeneral CounselSell12,416$32.10$398,553.60  
8/12/2020Katherine StuelandInsiderSell1,000$29.31$29,310.00  
7/17/2020Shelly D. GuyerCFOSell12,000$33.16$397,920.00  
7/15/2020Eric AguiarDirectorSell10,000$33.99$339,900.0010,000  
7/14/2020Katherine StuelandInsiderSell1,000$32.50$32,500.00  
7/13/2020E Lee BendekgeyCOOSell27,500$34.16$939,400.00245,811  
7/9/2020Robert L. NussbaumInsiderSell29,783$34.15$1,017,089.45  
6/12/2020Katherine StuelandInsiderSell1,000$16.34$16,340.00  
5/22/2020Robert L. NussbaumInsiderSell19,893$17.28$343,751.04  
5/20/2020E Lee BendekgeyCOOSell9,348$16.70$156,111.60  
5/20/2020Robert L. NussbaumInsiderSell6,864$16.70$114,628.80  
5/20/2020Sean E. GeorgeCEOSell25,500$16.70$425,850.00  
5/20/2020Shelly D. GuyerCFOSell5,250$16.70$87,675.00  
5/20/2020Thomas BridaGeneral CounselSell2,060$16.70$34,402.00  
5/13/2020Katherine StuelandInsiderSell1,000$17.56$17,560.00  
5/12/2020E Lee BendekgeyCOOSell18,665$18.11$338,023.15  
4/13/2020Katherine StuelandInsiderSell1,000$12.80$12,800.00  
3/16/2020E Lee BendekgeyCOOSell11,056$11.79$130,350.24198,230  
3/16/2020Katherine StuelandInsiderSell10,684$11.79$125,964.36224,786  
3/16/2020Sean E GeorgeCEOSell11,655$11.79$137,412.45563,721  
3/16/2020Thomas BridaGeneral CounselSell9,226$11.79$108,774.54175,094  
3/13/2020Katherine StuelandInsiderSell1,000$11.64$11,640.00224,786  
2/27/2020Katherine StuelandInsiderSell1,000$20.44$20,440.00  
2/26/2020E Lee BendekgeyCOOSell119,789$20.76$2,486,819.64148,656  
1/14/2020Katherine StuelandInsiderSell1,000$18.14$18,140.00  
12/13/2019Katherine StuelandInsiderSell1,000$17.08$17,080.00  
11/14/2019Katherine StuelandInsiderSell3,788$17.46$66,138.48  
9/17/2019Katherine StuelandInsiderSell3,788$21.40$81,063.20  
8/26/2019Randal W ScottInsiderSell40,000$24.59$983,600.00  
8/22/2019Geoffrey CrouseDirectorSell5,000$25.68$128,400.0029,259  
8/19/2019E Lee BendekgeyCOOSell21,265$25.29$537,791.85  
8/19/2019Robert L. NussbaumInsiderSell20,447$25.29$517,104.63  
8/19/2019Sean E. GeorgeCEOSell16,358$25.29$413,693.82  
8/19/2019Shelly D. GuyerCFOSell24,447$25.38$620,464.86  
8/19/2019Thomas BridaGeneral CounselSell13,663$25.29$345,537.27  
8/16/2019Katherine StuelandInsiderSell3,789$24.98$94,649.22  
7/15/2019Katherine StuelandInsiderSell3,789$22.49$85,214.61  
6/13/2019Katherine StuelandInsiderSell3,789$19.36$73,355.04  
5/28/2019Randal W ScottInsiderSell30,000$17.60$528,000.00  
5/20/2019E Lee BendekgeyCOOSell6,851$18.21$124,756.71  
5/20/2019Robert L. NussbaumInsiderSell7,202$18.21$131,148.42  
5/20/2019Sean E. GeorgeCEOSell24,282$18.21$442,175.22  
5/20/2019Shelly D. GuyerCFOSell9,513$18.03$171,519.39  
5/20/2019Thomas BridaGeneral CounselSell2,146$18.21$39,078.66  
5/15/2019Katherine StuelandInsiderSell1,000$18.36$18,360.00  
5/14/2019E Lee BendekgeyCOOSell4,657$18.78$87,458.46  
4/16/2019Katherine StuelandInsiderSell1,000$25.23$25,230.00  
3/15/2019Katherine StuelandInsiderSell1,000$23.49$23,490.00  
2/27/2019Katherine StuelandInsiderSell1,000$19.61$19,610.00  
2/27/2019Shelly D. GuyerCFOSell4,000$20.00$80,000.00  
2/26/2019E Lee BendekgeyCOOSell4,650$19.62$91,233.00  
2/25/2019Randal W ScottChairmanSell30,000$19.10$573,000.00  
1/16/2019Shelly D. GuyerCFOSell4,000$14.49$57,960.00  
1/15/2019Katherine StuelandInsiderSell1,000$13.59$13,590.00  
1/10/2019Robert L. NussbaumInsiderSell5,222$14.01$73,160.22  
12/17/2018Katherine StuelandInsiderSell1,000$11.44$11,440.00  
11/27/2018Eric AguiarDirectorSell10,000$13.50$135,000.00  
11/16/2018Patty DumondInsiderSell2,000$12.90$25,800.00  
9/20/2018Patty DumondInsiderSell645$16.58$10,694.1099,166  
9/18/2018Patty DumondInsiderSell290$16.67$4,834.3099,166  
9/9/2018Katherine StuelandInsiderSell595$13.62$8,103.90191,963  
5/15/2018E Lee BendekgeyCOOSell6,388$6.96$44,460.4852,396  
5/15/2018Robert L. NussbaumInsiderSell6,702$6.96$46,645.92  
5/15/2018Sean E. GeorgeCEOSell20,311$6.96$141,364.56  
5/15/2018Shelly D GuyerCFOSell5,135$6.96$35,739.6039,865  
5/15/2018Thomas BridaGeneral CounselSell1,979$6.96$13,773.84  
4/2/2018Randal W ScottInsiderBuy44,444$4.50$199,998.00  
3/28/2018Bros. Advisors Lp BakerMajor ShareholderBuy1,111,111$4.50$4,999,999.50  
See Full Table

SEC Filings (Institutional Ownership Changes) for Invitae (NYSE:NVTA)

78.60% of Invitae stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Invitae Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
2/25/2021Dimensional Fund Advisors LP178,031$7.44M0.0%+98.4%0.101%
2/25/2021Hsbc Holdings PLC48,371$2.03M0.0%N/A0.027%
2/24/2021Virtu Financial LLC52,699$2.20M0.2%+32.9%0.030%
2/24/2021Bank Julius Baer & Co. Ltd Zurich30,591$1.28M0.0%N/A0.017%
2/23/2021Principal Financial Group Inc.56,786$2.37M0.0%+50.0%0.032%
2/23/2021Orion Capital Management LLC750$31K0.0%N/A0.000%
2/19/2021Rehmann Capital Advisory Group390$0.26M0.0%N/A0.000%
2/19/2021Albion Financial Group UT3,800$0.16M0.0%N/A0.002%
2/19/2021Colonial River Wealth Management LLC4,800$0.25M0.1%N/A0.003%
2/18/2021Eudaimonia Partners LLC916$38K0.0%N/A0.001%
2/18/2021Truist Financial Corp14,430$0.60M0.0%+24.4%0.008%
2/17/2021IHT Wealth Management LLC24,033$1.01M0.1%+3.0%0.014%
2/17/2021Ambassador Advisors LLC7,700$0.32M0.1%N/A0.004%
2/17/2021Cetera Investment Advisers6,093$0.26M0.0%N/A0.003%
2/17/2021Pine Ridge Advisers LLC20,000$0.84M0.3%N/A0.011%
2/16/2021Squarepoint Ops LLC150,811$6.31M0.0%+892.7%0.085%
2/16/2021Glenmede Trust Co. NA22,286$0.93M0.0%+9.7%0.013%
2/16/2021Brookfield Asset Management Inc.5,334$0.22M0.0%-67.0%0.003%
2/16/2021Paloma Partners Management Co32,929$1.38M0.0%N/A0.019%
2/16/2021Tudor Investment Corp Et Al47,975$2.01M0.1%N/A0.027%
2/16/2021Nuveen Asset Management LLC820,476$34.30M0.0%+7.0%0.464%
2/16/2021Guggenheim Capital LLC71,923$3.01M0.0%N/A0.041%
2/16/2021Price T Rowe Associates Inc. MD2,112,725$88.33M0.0%+89.5%1.196%
2/16/2021Clear Perspective Advisors LLC35,095$1.47M0.6%+73.0%0.020%
2/16/2021Virginia Retirement Systems ET AL19,000$0.79M0.0%+54.5%0.011%
2/16/2021ETF Managers Group LLC10,175$0.45M0.0%-32.7%0.006%
2/16/2021Schroder Investment Management Group11,318$0.47M0.0%+96.4%0.006%
2/16/2021Graham Capital Management L.P.101,649$4.25M0.2%N/A0.058%
2/16/2021Parametrica Management Ltd10,635$0.45M0.3%N/A0.006%
2/16/2021Charles Schwab Investment Management Inc.966,649$40.42M0.0%+16.8%0.547%
2/16/2021Ma Investment Partnership LP50,000$2.09M1.4%N/A0.028%
2/13/2021American International Group Inc.71,693$3M0.0%+3.9%0.041%
2/12/2021Stifel Financial Corp23,702$0.99M0.0%-4.1%0.013%
2/12/2021Brevan Howard Capital Management LP92,750$3.88M0.8%N/A0.052%
2/12/2021Capital Impact Advisors LLC275,000$11.50M2.8%+37.5%0.156%
2/12/2021Checchi Capital Advisers LLC7,926$0.33M0.0%-6.8%0.004%
2/12/2021Raymond James Financial Services Advisors Inc.32,448$1.36M0.0%+62.2%0.018%
2/12/2021LPL Financial LLC155,495$6.50M0.0%+25.5%0.088%
2/12/2021The Manufacturers Life Insurance Company 69,081$2.89M0.0%+4.4%0.039%
2/12/2021Montag A & Associates Inc.1,846$77K0.0%N/A0.001%
2/12/2021Alpha Paradigm Partners LLC11,023$0.46M0.2%N/A0.006%
2/12/2021Magnetar Financial LLC7,947$0.33M0.0%N/A0.004%
2/12/2021Regal Investment Advisors LLC8,964$0.38M0.0%N/A0.005%
2/12/2021Mercer Global Advisors Inc. ADV62,511$2.61M0.0%-0.5%0.035%
2/11/2021Nikko Asset Management Americas Inc.11,255,614$470.60M2.7%-0.1%6.370%
2/11/2021Longitude Cayman Ltd.120,000$5.02M2.4%N/A0.068%
2/11/2021Stelac Advisory Services LLC3,718$0.16M0.0%N/A0.002%
2/11/2021Trexquant Investment LP21,764$0.91M0.1%N/A0.012%
2/11/2021Northern Trust Corp1,523,564$63.70M0.0%+1.9%0.862%
2/11/2021Exencial Wealth Advisors LLC7,373$0.31M0.0%+6.7%0.004%
2/11/2021Barclays PLC72,546$3.03M0.0%+34.9%0.041%
2/11/2021Valeo Financial Advisors LLC4,550$0.19M0.0%+5.0%0.003%
2/11/2021Teacher Retirement System of Texas11,681$0.49M0.0%+74.1%0.007%
2/11/2021Steward Partners Investment Advisory LLC2,165$91K0.0%+1,212.1%0.001%
2/11/2021Skandinaviska Enskilda Banken AB publ 25,158$1.05M0.0%-27.0%0.014%
2/11/2021Dynamic Technology Lab Private Ltd59,300$2.48M0.4%+537.3%0.034%
2/11/2021Oppenheimer & Co. Inc.69,610$2.91M0.1%+44.7%0.039%
2/11/2021Cresset Asset Management LLC33,670$1.41M0.0%+18.6%0.019%
2/10/2021Rhumbline Advisers150,131$6.28M0.0%+5.2%0.085%
2/10/2021Aequim Alternative Investments LP107,170$0.20M0.1%-7.6%0.061%
2/10/2021Brighton Jones LLC16,671$0.70M0.0%N/A0.009%
2/10/2021Clearbridge Investments LLC2,126,744$88.92M0.1%0.0%1.204%
2/10/2021Boston Private Wealth LLC23,758$0.99M0.0%N/A0.013%
2/10/2021Artisan Partners Limited Partnership898,546$37.57M0.0%+2.6%0.509%
2/10/2021Bluefin Capital Management LLC5,995$0.25M0.0%N/A0.003%
2/10/2021Mckinley Capital Management LLC Delaware76,170$3.19M0.2%+61.7%0.043%
2/10/2021Harvest Fund Management Co. Ltd1,722$71K0.0%-29.6%0.001%
2/9/2021Wells Fargo & Company MN801,303$33.50M0.0%-27.0%0.453%
2/9/2021Advisory Services Network LLC25,871$1.08M0.0%+265.2%0.015%
2/9/2021Duality Advisers LP61,824$2.59M0.2%N/A0.035%
2/9/2021Thornburg Investment Management Inc.209,018$8.74M0.1%N/A0.118%
2/9/2021Keybank National Association OH7,934$0.33M0.0%+6.7%0.004%
2/9/2021Bank of New York Mellon Corp562,410$23.52M0.0%-50.9%0.318%
2/9/2021Menard Financial Group LLC8,162$0.34M0.4%+7.9%0.005%
2/9/2021Illinois Municipal Retirement Fund6,210$0.26M0.0%N/A0.004%
2/9/2021Indie Asset Partners LLC8,875$0.37M0.4%N/A0.005%
2/9/2021Sigma Planning Corp34,847$1.46M0.0%+20.8%0.020%
2/9/2021Lord Abbett & CO. LLC838,343$35.05M0.1%+40.2%0.474%
2/9/2021Chartwell Investment Partners LLC31,572$1.32M0.0%+53.5%0.018%
2/9/2021CI Investments Inc.10,829$0.45M0.0%N/A0.006%
2/9/2021ProShare Advisors LLC25,574$1.07M0.0%+80.7%0.014%
2/8/2021CIBC World Markets Inc.23,821$1M0.0%+247.8%0.013%
2/8/2021Alliancebernstein L.P.174,100$7.28M0.0%+0.9%0.099%
2/8/2021FDx Advisors Inc.22,385$0.94M0.0%-12.5%0.013%
2/8/2021State Board of Administration of Florida Retirement System47,859$2M0.0%-1.3%0.027%
2/8/2021New York State Common Retirement Fund251,990$10.54M0.0%-0.2%0.143%
2/8/2021Sei Investments Co.39,188$1.64M0.0%-8.4%0.022%
2/8/2021Fagan Associates Inc.92,040$3.85M1.0%-25.6%0.052%
2/8/2021Carnegie Capital Asset Management LLC15,200$0.64M0.0%+15.2%0.009%
2/8/2021Russell Investments Group Ltd.19,377$0.81M0.0%+37.4%0.011%
2/6/2021Phoenix Wealth Advisors29,829$1.25M0.9%N/A0.017%
2/5/2021Gamco Investors INC. ET AL89,500$3.74M0.0%-1.6%0.051%
2/5/2021Teton Advisors Inc.14,500$0.61M0.1%-48.2%0.008%
2/5/2021Gabelli Funds LLC7,500$0.31M0.0%-13.8%0.004%
2/5/2021Capital Wealth Alliance LLC61,200$3.28M2.4%N/A0.035%
2/5/2021Koshinski Asset Management Inc.2,066$0.29M0.0%N/A0.001%
2/5/2021Convergence Investment Partners LLC3,525$0.15M0.1%N/A0.002%
2/5/2021Navellier & Associates Inc5,885$0.25M0.0%N/A0.003%
2/5/2021Aperio Group LLC32,968$1.38M0.0%+26.3%0.019%
2/5/2021Swiss National Bank298,500$12.48M0.0%+5.4%0.169%
Data available starting January 2016

See Full Table
Invitae logo
Invitae Corporation, a medical genetics company, processes DNA-containing samples, analyzes information related to patient-specific genetic variation, and generates test reports for clinicians and their patients in the United States, Canada, and internationally. It offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, metabolic conditions, and rare diseases; prenatal and perinatal genetic tests; and non-invasive prenatal screening products. The company also provides preimplantation and carrier screening for inherited disorders; products for prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders; a platform for collecting, curating, coordinating, and delivering data from patients and clinicians; and CancerGene Connect, a platform for collecting and managing genetic family histories to deliver personalized genetic risk information. It serves patients, healthcare providers, and biopharma and advocacy partners. Invitae Corporation has a collaboration with Gene Therapies Ltd. for the detection of lysosomal storage disorders in children; a research collaboration with Pacific Biosciences of California, Inc. for the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy; and a project with Bristol Myers Squibb, Janssen Research & Development, LLC, Novartis, and Genentech to develop a panel for molecular residual disease detection in patients with acute myeloid leukemia to support clinical trial testing across various drug development programs. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
Read More

Today's Range

Now: $39.80
$38.15
$42.38

50 Day Range

MA: $50.65
$42.09
$56.93

52 Week Range

Now: $39.80
$7.41
$61.59

Volume

5,650,312 shs

Average Volume

4,240,884 shs

Market Capitalization

$7.03 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.11

Who are the company insiders with the largest holdings of Invitae?

Invitae's top insider shareholders include:
  1. Jason W Myers (Insider)
  2. Sean E George (CEO)
  3. E Lee Bendekgey (COO)
  4. Katherine Stueland (Insider)
  5. Thomas Brida (General Counsel)
  6. Geoffrey Crouse (Director)
  7. Eric Aguiar (Director)
  8. Kenneth D Knight (COO)
  9. Randal W Scott (Insider)
  10. Robert F Werner (CAO)
  11. Robert L Nussbaum (Insider)
  12. Sean E George (CEO)
  13. Shelly D Guyer (CFO)

Who are the major institutional investors of Invitae?

Invitae's top institutional shareholders include:
  1. Sumitomo Mitsui Trust Holdings Inc. — 6.37%
  2. Nikko Asset Management Americas Inc. — 6.37%
  3. Clearbridge Investments LLC — 1.20%
  4. Price T Rowe Associates Inc. MD — 1.20%
  5. Northern Trust Corp — 0.86%
  6. Victory Capital Management Inc. — 0.63%

Which institutional investors are selling Invitae stock?

In the last quarter, NVTA stock was sold by these institutional investors:
  1. Victory Capital Management Inc.
  2. Bank of New York Mellon Corp
  3. Wells Fargo & Company MN
  4. State of Michigan Retirement System
  5. Fagan Associates Inc.
  6. State of Wisconsin Investment Board
  7. Nikko Asset Management Americas Inc.
  8. Teton Advisors Inc.
Within the last year, company insiders that have sold Invitae company stock include:
  1. Jason W Myers (Insider)
  2. Sean E George (CEO)
  3. E Lee Bendekgey (COO)
  4. Katherine Stueland (Insider)
  5. Thomas Brida (General Counsel)
  6. Geoffrey Crouse (Director)
  7. Eric Aguiar (Director)
  8. Kenneth D Knight (COO)
  9. Randal W Scott (Insider)
  10. Robert F Werner (CAO)
  11. Robert L Nussbaum (Insider)
  12. Sean E George (CEO)

Which institutional investors are buying Invitae stock?

During the last quarter, NVTA stock was acquired by institutional investors including:
  1. Price T Rowe Associates Inc. MD
  2. Lord Abbett & CO. LLC
  3. Thornburg Investment Management Inc.
  4. Charles Schwab Investment Management Inc.
  5. Squarepoint Ops LLC
  6. Longitude Cayman Ltd.
  7. Graham Capital Management L.P.
  8. Brevan Howard Capital Management LP
This undiscovered CBD play is on the verge of disrupting the industry
With recent health Canada approval they are poised to explode
Read more here